Billionaire Profile
G.V. Prasad
Global Rank
#2420

Image: Embassy of India, Astana, Kazakhstan | GODL-India | via Wikimedia Commons

G.V. Prasad

CEO, Pharmaceuticals
INDIA
Real-Time Net Worth
$1.581B
Estimated based on Pharmaceuticals stock value as of March 6, 2026
+0.35% (24h)
Age
65
Source
Pharmaceuticals
Industry
Healthcare
Citizenship
INDIA

Biography

G.V. Prasad, born in 1960, is a prominent figure in the Indian pharmaceutical industry, currently serving as the Co-Chairman and Managing Director of Dr. Reddy's Laboratories. His estimated net worth in 2024 is $1.5 billion, reflecting his significant contributions to the healthcare sector. Prasad's source of wealth is primarily from pharmaceuticals. He is recognized for his crucial role in transforming Dr. Reddy's Laboratories into a global generics powerhouse. Throughout his career, he has spearheaded innovative business strategies and championed principles of transparency and ethical practices, driving the company's success. His leadership has earned him accolades and recognition in the industry.

Fact Checked
Verified by Editorial Team
Live Data
Updated 3/6/2026

Wealth Over Time

In-Depth Profile

Early Life and Education

G.V. Prasad was born in Nellore, Andhra Pradesh, India, in 1960. He received his early education in Hyderabad and Nellore. Prasad pursued a Bachelor of Science in Engineering at Alagappa College of Technology. He continued his studies at the Illinois Institute of Technology in Chicago and earned an MBA from Purdue University in 1983.

Rise to Success

In 1985, Prasad co-founded Benzex Labs, a pharmaceutical enterprise. Benzex was later acquired by Dr. Reddy's Laboratories. In 1990, Prasad became the CEO and MD of Cheminor Drugs Ltd. In 2001, Cheminor Drugs merged with Dr. Reddy's Laboratories, and Prasad became the vice-chairman and CEO of the merged entity. He is credited with transforming Dr. Reddy's Laboratories into a global generics powerhouse, envisioning newer business platforms, including Custom Pharmaceutical business and Specialty pharmaceuticals.

Key Business Strategies

Prasad's key strategies include a focus on innovation, transparency, and ethical business practices. He has been instrumental in the global expansion of Dr. Reddy's Laboratories, particularly in developed markets. His emphasis on sustainable manufacturing and business practices has also been a significant factor, including adopting green technologies and processes.

Philanthropy

Prasad is involved in various environmental initiatives and is a member of the Andhra Pradesh chapter of the Worldwide Fund for Nature and the 'Acumen Fund'.

Career Milestones

1985

Co-founded Benzex Labs

Founded Benzex Labs, a pharmaceutical enterprise.

1990

CEO and MD of Cheminor Drugs Ltd

Served as the CEO and MD of Cheminor Drugs Ltd.

2001

Vice-Chairman and CEO of Dr. Reddy's Laboratories

Became vice-chairman and CEO of Dr. Reddy's Laboratories after the merger of Cheminor Drugs.

2023

Launched Nerivio

Dr. Reddy's launched Nerivio, a wearable therapy device to treat migraines

Philanthropy & Social Impact

Environmental Conservation

Environmental Initiatives

Undisclosed

Involved with the Andhra Pradesh chapter of the Worldwide Fund for Nature.

Poverty Alleviation

Acumen Fund

Undisclosed

Member of the 'Acumen Fund', a non-profit venture.

Business Philosophy & Leadership

Notable Quotes

""We started asking the question why we were not the darling of investors. We found out that they want to see less volatility in business, they prefer a model that is predictable and profitable,”"

Leadership Principles

Innovation

Focus on research and development and the creation of new business platforms.

Transparency

Maintain open and honest business practices.

Business Ethics

Prioritize ethical conduct in all business dealings.

Sustainable Practices

Implement green technologies and processes to reduce the company's ecological footprint.